Juan Vera's most recent trade in Marker Therapeutics Inc was a trade of 50,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | Juan Vera | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 2,409,928 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 2,374,928 | - | 0 | Common Stock | |
| Marker Therapeutics Inc | Juan Vera | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 46,487 | 46,487 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 140,823 | 2,705,310 (5%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 24 Mar 2022 | 33,465 | 2,671,845 (5%) | 0% | 0.5 | 16,224 | Common Stock |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Juan Vera | Chief Development Officer | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 571,428 | 2,564,487 (5%) | 1% | 1.8 | 999,999 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.73 per share. | 01 Mar 2021 | 20,584 | 2,371,610 | - | 38.7 | 797,266 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 01 Mar 2021 | 11,570 | 2,392,194 | - | 38.3 | 442,842 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.30 per share. | 01 Mar 2021 | 9,001 | 2,357,719 | - | 38.3 | 344,708 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.63 per share. | 01 Mar 2021 | 7,546 | 2,339,928 | - | 38.6 | 291,518 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 01 Mar 2021 | 7,142 | 2,347,474 | - | 38.2 | 272,954 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 37.28 per share. | 01 Mar 2021 | 4,190 | 2,366,720 | - | 37.3 | 156,189 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 39.10 per share. | 01 Mar 2021 | 1,803 | 2,355,916 | - | 39.1 | 70,500 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 01 Mar 2021 | 1,300 | 2,354,616 | - | 37.0 | 48,114 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 01 Mar 2021 | 700 | 2,370,910 | - | 39.5 | 27,671 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 41.79 per share. | 19 Feb 2021 | 13,233 | 2,426,935 | - | 41.8 | 553,011 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 42.80 per share. | 19 Feb 2021 | 11,050 | 2,412,994 | - | 42.8 | 472,907 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 39.11 per share. | 19 Feb 2021 | 4,825 | 2,406,664 | - | 39.1 | 188,692 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 41.58 per share. | 19 Feb 2021 | 2,891 | 2,424,044 | - | 41.6 | 120,215 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 19 Feb 2021 | 2,300 | 2,404,364 | - | 40.1 | 92,294 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.33 per share. | 19 Feb 2021 | 1,125 | 2,411,489 | - | 38.3 | 43,116 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 40.97 per share. | 19 Feb 2021 | 600 | 2,403,764 | - | 41.0 | 24,582 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 43.40 per share. | 19 Feb 2021 | 380 | 2,412,614 | - | 43.4 | 16,493 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 40.44 per share. | 18 Feb 2021 | 4,032 | 2,443,878 | - | 40.4 | 163,069 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 41.49 per share. | 18 Feb 2021 | 3,710 | 2,440,168 | - | 41.5 | 153,923 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 39.48 per share. | 18 Feb 2021 | 1,200 | 2,447,910 | - | 39.5 | 47,376 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 41.79 per share. | 16 Feb 2021 | 9,434 | 2,457,536 | - | 41.8 | 394,284 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 41.26 per share. | 16 Feb 2021 | 4,060 | 2,449,110 | - | 41.3 | 167,507 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 38.71 per share. | 16 Feb 2021 | 2,000 | 2,454,570 | - | 38.7 | 77,421 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 16 Feb 2021 | 1,400 | 2,453,170 | - | 40.0 | 56,003 | Common Stock |
| Kalaris Therapeutics Inc. | Juan Vera | Director | Sale of securities on an exchange or to another person at price $ 42.53 per share. | 16 Feb 2021 | 966 | 2,456,570 | - | 42.5 | 41,081 | Common Stock |
| Marker Therapeutics Inc | Juan Vera | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) | |
| Kalaris Therapeutics Inc. | Juan Vera | Director | 03 Aug 2020 | 3,631,293 | 0 | - | - | Series A-3 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | Juan Vera | Director | 03 Aug 2020 | 2,436,773 | 2,466,970 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | Juan Vera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |